Bunker Hill Announces Election to Issue Shares in Satisfaction of Debenture Interest Payment Obligations
September 20, 2024 19:00 ET
|
Bunker Hill Mining Corp.
VANCOUVER, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR; OTCQB: BHILL) announces that it has elected to issue an...
Viridien selected to support technology-driven mineral exploration program in Oman
September 19, 2024 01:30 ET
|
Viridien
Paris, France – September 19, 2024 Viridien has been awarded a comprehensive remote sensing program by Minerals Development Oman (MDO), the leading mining entity in the Sultanate of Oman, to...
Viridien sélectionné pour sa technologie de pointe en support d’un programme d’exploration minier en Oman
September 19, 2024 01:30 ET
|
Viridien
Paris, France – Septembre 19, 2024 Viridien s’est vu attribuer un programme complet de télédétection par Minerals Development Oman (MDO), la principale entité minière du Sultanat d’Oman, afin...
COURTOIS SA : Rapports semestriels au 30 juin 2024
September 18, 2024 11:30 ET
|
COURTOIS
COURTOIS SA : Rapports semestriels au 30 juin 2024
Pièce jointe
CSArapports30062024
...
BridgeBio Announces Infigratinib Is the First Ever Investigational Therapeutic Option for Achondroplasia to Be Awarded Breakthrough Therapy Designation by the FDA
September 17, 2024 07:30 ET
|
BridgeBio Pharma, Inc.
- Breakthrough Therapy Designation was granted based on preliminary clinical evidence from the PROPEL 2 clinical trial, meeting the FDA’s requirement of potentially demonstrating substantial...
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 16, 2024 07:00 ET
|
EyePoint Pharmaceuticals, Inc.
WATERTOWN, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of...
Virbac : Half-yearly financial report 2024
September 13, 2024 12:15 ET
|
Virbac
Please find attached 2024 Half-yearly financial report of Virbac
Attachment
Half-Yearly Financial Report_2024 for publication
...
Virbac : Rapport financier semestriel 2024
September 13, 2024 12:15 ET
|
Virbac
Ci-joint le rapport financier semestriel 2024 de Virbac
Pièce jointe
Rapport financier semestriel_2024 pour publication
...
Fancamp Files Technical Report on New Brunswick Riley Brook Project in Prospective Copper-Gold Region
September 13, 2024 07:45 ET
|
Fancamp Exploration Ltd.
VANCOUVER, British Columbia, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce that it has filed an...
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares
September 12, 2024 22:34 ET
|
Centessa Pharmaceuticals plc
BOSTON and LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are...